Use of platelets rich plasma in fine refractory endometrium
Revista Reproducción
pdf (Español (España))

Keywords

Platelet-Rich Plasma
Endometrium
Instillation

How to Cite

Baum, E., Yanina, A., Castro , F., Pasqualini R., A. ., Pasqualini R., S. ., & Vinci, V. V. (2021). Use of platelets rich plasma in fine refractory endometrium. Revista Reproducción, 36(1). Retrieved from http://www.revistareproduccion.org.ar/index.php/revistareproduccion/article/view/20

Abstract

Study question: In patients with thin endometrium, refractory to usual hormonal treatments, could the use of autologous Platelet Rich Plasma, instilled in the uterine cavity, contribute as a synergistic factor in endometrial development?

Summary response: The use of endometrial Platelet Rich Plasma in this group of patients demonstrated a favorable effect in terms of increasing endometrial thickness and morphology.

What is already known: The thin endometrium, refractory to the usual hormonal treatments, is a challenge in medical treatment; Scientific evidence demonstrates a potential benefit of autologous Platelet Rich Plasma on the endometrium, with an effect in relation to the increase in endometrial thickness and / or changes that would favor correct embryo implantation.

Design: Retrospective observational pilot study, single group of 22 patients with thin endometrium refractory to usual hormonal treatments, with evaluation of paired samples from December 2018 to July 2020.

Materials and Methods: 22 patients were indicated for treatment with Rich Plasma in endometrial platelets due to a history of refractory thin endometrium in normal hormonal substituted cycles. Analysis of dichotomous and nominal quantitative and qualitative variables was use.

Results: The mean endometrial thickness prior to instillation was 5.9 mm (4.4 - 6.8 mm) and post-instillation was 7.2 mm (6.3-8.7 mm) trilaminar. The implantation rate was 63.63% (14 patients) and the clinical pregnancy rate 50% (11 patients). 

Limitations: retrospective evaluations and use of other concomitant therapies, previously indicated by underlying causes of endometrial molecular studies.

Implication of the findings: Although there are few cases presented, this technique is seen as promising in this group of patients with thin endometrium, refractory to the usual treatments, being necessary to increase the casuistry and randomize groups of patients to evaluate if the trend is maintained.

pdf (Español (España))

References

El - Toukhy T, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril 2008; 89:832-9.

Richter KS, et al. Relationship between endometrial thickness and embryo implantation, based on 1294 cycles of in vitro fertilization with transfer of two blastocyst-staged embryos. Fertil Steril. 2007; 87:53-9

Check, J.H., Lurie, D., Dietterich, C., Callan, C., Baker, A.Adverse effect of a homogeneous hyperechogenic endometrial sonographic pattern, despite adequate endometrial thickness on pregnancy rates following in-vitro fertilization. 1993. Hum. Reprod. 8, 1293–1296.

Lebovitz O et al. Treating patients with "thin" endometrium - an ongoing challenge. Gynecol Endocrinol. 2014 Jun;30 (6):409-14. doi: 10.3109/09513590.2014.906571. Epub 2014 Apr 2.

Dix, E., Check, J.H. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. 2010. Clin. Exp. Obstet. Gynecol. 37, 15–16

Kasius, A., Smit, J.G., Torrance, H.L., Eijkemans, M.J., Mol, B.W., Opmeer, B.C., Broekmans, F.J. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. 2014. Hum. Reprod. Update 20, 530–541

Galliano, D., Bellver, J., Díaz-García, C., Simon, C., Pellicer, A. ART and uterine pathology: how relevant is the maternal side for implantation? 2015. Hum. Reprod. Update 21, 13–38.

Schipper, E., Valle, R.F., Nezhat, C. Intrauterine Adhesions: Hysteroscopic Evaluation and Treatment, Prevention and Management. 2010. 3rd Ed. Society of Laparoscopic Surgeons. 1–3.

Hooker, A.B., Lemmers, M., Thurkow, A.L., Heymans, M.W., Opmeer, B.C., Brölmann, H.A., Mol, B.W., Huirne, J.A. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and longterm reproductive outcome. 2014. Hum. Reprod. Update 20, 2062– 2078.

Salzani, A., Angerame, D., Erbolato, J.R., BedOne, A.J., Urban, I.M. Prevalence of uterine synechia after evacuation curettage abortion. 2007. Sao Paulo Med. J. 125, 261–264

Juan A Garcia-Velasco. Strategies to manage refractory endometrium: state of the art in 2016. Reproductive BioMedicine Online (2016) 32, 474–489

Giulia Mariani et al. Estrategias de mejora de la receptividad endometrial. Revista Iberoamericana de Fertilidad y Reproducción Humana ⁄ Vol. 34 nº 1 Enero-Febrero-Marzo 2017

Chang Y., Li J., Chen Y., Wei L., Yang X., Shi Y., et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015; 8(1):1286–1290.

Leila Nazari M.D et al. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod BioMed Vol. 14. No. 10. pp: 625-628, October 2016

M. A.Santana Suárez, M.Álvarez Sánchez, Y. Machado Rider, C. Pérez Matos, A. Torres Afonso, L. Roldán Gutiérrez. Treatment with rich platelets autologous plasma in a sterile patient with suspected refractory endometrium. Revista Iberoamericana de Fertilidad y Reproducción Humana ⁄ Vol. 34 nº 2 Abril-Mayo-Junio 2017

Christgau M, Moder D, Hiller KA, Dada A, Schmitz G and Schmalz G. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin Periodontol 2006; 33: 837-845.

Vogrin M, Rupreht M, Crnjac A, Dinevski D, Krajnc Z and Recnik G. The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschr 2010; 122 Suppl 2: 91-95.

Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001; 10: 225-228. [15] Alio JL, Arnalich-Montiel F and Rodriguez AE. The role of “eye platelet rich plasma” (E-PRP) for wound healing in ophthalmology. Curr Pharm Biotechnol 2012; 13: 1257-1265.

Nagata MJ, de Campos N, Messora MR, Pola NM, Santinoni CS, Bomfim SR, Fucini SE, Ervolino E, de Almeida JM, Theodoro LH and Garcia VG. Platelet-rich plasma, low-level laser therapy, or their combination promotes periodontal regeneration in fenestration defects: a preliminary in vivo study. J Periodontol 2014; 85: 770- 778.

Dr Claudio Mingo Saluzzi, Dr. Martin Pombo, Dr. Lazaro Larrabe. TRABAJO DE ACTUALIZACIÓN “Plasma rico en plaquetas en cirugía ortopédica y traumatológica.” ARTROSCOPIA | VOL. 14, Nº 2 : 145-151 | 2007

Downloads

Download data is not yet available.